Tobramycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 72603-160

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 72603-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

How-supplied (How Supplied)

How-supplied (How Supplied)
A data table presenting the NDC number 72603-160-06 and its corresponding fill volume for Tobramycin injection, USP 1.2 g per vial, packaged as six vials in one carton.*
FDA Label Image

Tobramycin-carton-6pk.jpg (Tobramycin Carton 6pk Northstar)

Tobramycin-carton-6pk.jpg (Tobramycin Carton 6pk Northstar)
Box packaging label for Tobramycin for Injection, USP, 1.2 grams per vial, lyophilized powder for solution. The label states it is a pharmacy bulk package for intravenous use only, containing 6 vials of 1.2 g strength each. Manufactured by Northstar Rx LLC with storage and preparation instructions included, along with a barcode and lot details.*
FDA Label Image

Tobramycin-container-label (Tobramycin Container Label Northstar)

Tobramycin-container-label (Tobramycin Container Label Northstar)
Tobramycin for Injection, USP 1.2 grams per vial powder label for lyophilized injection prepared for intravenous use. The label includes pharmacy bulk package warnings and preparation instructions. Manufactured for Northstar Rx LLC, with manufacturing by Gland Pharma Ltd., India. The label features storage information, lot and expiration date areas, and barcode.*
FDA Label Image

Tobramycin-nomogram (Tobramycin Nomogram)

Tobramycin-nomogram (Tobramycin Nomogram)
A reduced dosage nomogram chart plotting percent of normal dosage from Table 3 against serum creatinine (mg/100 mL) and creatinine clearance (mL/min/1.73 m²). The graph shows a linear decrease in dosage percentage as serum creatinine increases and creatinine clearance decreases, illustrating dose adjustments based on kidney function.*
FDA Label Image

Tobramycin-structure (Tobramycin Structure)

Tobramycin-structure (Tobramycin Structure)
Chemical structure of Tobramycin, depicting its molecular arrangement with rings, amino, hydroxyl, and ether groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.